Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
PaperCitations, authors & open-access status
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 346 citations, 2018 year and bronze oa status.
346
Citations
2018
Year
bronze
OA Status